Edges in Network
Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
Node | GBP2 |
Upstream (Parents) |
---|
(<<) ARHGAP25 → GBP2 |
(<<) CASP1 → GBP2 |
(<<) CASP4 → GBP2 |
(<<) CCND2 → GBP2 |
(<<) CD274 → GBP2 |
(<<) HLA-A → GBP2 |
(<<) HLA-DOA → GBP2 |
(<<) INPP5D → GBP2 |
(<<) IRF1 → GBP2 |
(<<) JAK3 → GBP2 |
(<<) MLKL → GBP2 |
(<<) NR3C1 → GBP2 |
(<<) PIK3R5 → GBP2 |
(<<) PTK2B → GBP2 |
(<<) STAT4 → GBP2 |
(<<) STK17A → GBP2 |
(<<) TGM2 → GBP2 |
(<<) UBE2L6 → GBP2 |
(<<) VAV1 → GBP2 |
Downstream (Children) |
---|
GBP2 → ADORA2B (>>) |
GBP2 → ASB2 (>>) |
GBP2 → BLNK (>>) |
GBP2 → CEBPA (>>) |
GBP2 → CHST10 (>>) |
GBP2 → EPHA4 (>>) |
GBP2 → HMGA2 (>>) |
GBP2 → IGFBP2 (>>) |
GBP2 → KCNG1 (>>) |
GBP2 → KYNU (>>) |
GBP2 → SERPINB2 (>>) |
GBP2 → SMO (>>) |
GBP2 → SPINK5 (>>) |